The effects of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors for people with cardiovascular disease

Added 68 days ago (17.11.2021)
Authors: Kanie T;Mizuno A;Takaoka Y;Suzuki T;Yoneoka D;Nishikawa Y;Tam WW;Morze J;Rynkiewicz A;Xin Y;Wu O;Providencia R;Kwong JSW
Read article